HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors
HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors
Recruiting · NCT06822998 · Registry updated 2025-08-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Early phase 1 | 2025-08-17 | NCT06822998 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| HighField Biopharmaceuticals Corporation | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| West China Hospital of Sichuan University | Chengdu | China | 117 |